NO883367L - Celleoverflate-antigen-paavisningsmetode. - Google Patents

Celleoverflate-antigen-paavisningsmetode.

Info

Publication number
NO883367L
NO883367L NO883367A NO883367A NO883367L NO 883367 L NO883367 L NO 883367L NO 883367 A NO883367 A NO 883367A NO 883367 A NO883367 A NO 883367A NO 883367 L NO883367 L NO 883367L
Authority
NO
Norway
Prior art keywords
cell surface
surface antigen
detection systems
present
provides
Prior art date
Application number
NO883367A
Other languages
English (en)
Other versions
NO172910B (no
NO883367D0 (no
NO172910C (no
Inventor
Robert Mcmillan
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/936,125 external-priority patent/US4810632A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of NO883367L publication Critical patent/NO883367L/no
Publication of NO883367D0 publication Critical patent/NO883367D0/no
Publication of NO172910B publication Critical patent/NO172910B/no
Publication of NO172910C publication Critical patent/NO172910C/no

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/29—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the position or the direction of light beams, i.e. deflection
    • G02F1/31—Digital deflection, i.e. optical switching
    • G02F1/313—Digital deflection, i.e. optical switching in an optical waveguide structure
    • G02F1/3131—Digital deflection, i.e. optical switching in an optical waveguide structure in optical fibres
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/35—Non-linear optics
    • G02F1/3515—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam
    • G02F1/3517—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer
    • G02F1/3519—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer of Sagnac type, i.e. nonlinear optical loop mirror [NOLM]
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F3/00—Optical logic elements; Optical bistable devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Power Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
NO883367A 1986-12-01 1988-07-29 Fremgangsmaate for utproeving av en proeve av celler med hensyn til naervaer av celleoverflateantigen NO172910C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/936,125 US4810632A (en) 1986-12-01 1986-12-01 Cell surface antigen detection method
US07/124,905 US5176998A (en) 1986-12-01 1987-11-24 Cell surface antigen detection method
PCT/US1987/003129 WO1988004432A1 (en) 1986-12-01 1987-11-25 Cell surface antigen detection method

Publications (4)

Publication Number Publication Date
NO883367L true NO883367L (no) 1988-07-29
NO883367D0 NO883367D0 (no) 1988-07-29
NO172910B NO172910B (no) 1993-06-14
NO172910C NO172910C (no) 1993-09-22

Family

ID=26823073

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883367A NO172910C (no) 1986-12-01 1988-07-29 Fremgangsmaate for utproeving av en proeve av celler med hensyn til naervaer av celleoverflateantigen

Country Status (9)

Country Link
US (2) US5176998A (no)
EP (1) EP0290595B1 (no)
JP (1) JP2803824B2 (no)
AT (1) ATE123341T1 (no)
AU (1) AU594554B2 (no)
DE (1) DE3751331T2 (no)
DK (1) DK173838B1 (no)
FI (1) FI95082C (no)
NO (1) NO172910C (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method
US5525461A (en) * 1991-11-01 1996-06-11 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using total leukocyte surface antigens
US5731425A (en) * 1994-10-28 1998-03-24 Eastman Kodak Company Polypeptide surface marker for cells
US6984526B2 (en) 1995-02-08 2006-01-10 University Of South Florida Spectrophotometric method for determining the viability of a sample containing platelets
US6330058B1 (en) 1999-04-14 2001-12-11 University Of South Florida Spectrophotometric method and apparatus for blood typing
US6379903B1 (en) 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
AU2009322607B2 (en) 2008-12-01 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detection of complement fixing antibodies
WO2012070964A1 (ru) * 2010-11-22 2012-05-31 Farber Boris Slavinovich Модифицированные олигопептиды с противораковыми свойствами и способ их получения
JP6548631B2 (ja) * 2013-03-14 2019-07-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ドナー特異的抗体を検出する方法及び該方法を実施するためのシステム
US10527613B2 (en) 2015-11-10 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biomarker detection methods and systems and kits for practicing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4643971A (en) * 1983-03-11 1987-02-17 Sloan-Kettering Institute Monoclonal antibodies to human bladder and ureter cancers and method
EP0149168B1 (en) * 1983-12-19 1991-04-24 Daiichi Pure Chemicals Co. Ltd. Immunoassay
US4695538A (en) * 1984-06-01 1987-09-22 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cell surface antigens
EP0169729A3 (en) * 1984-07-23 1988-08-03 Becton Dickinson and Company Recovery of cell receptors
US4670394A (en) * 1984-11-16 1987-06-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C
US4810632A (en) * 1986-12-01 1989-03-07 Scripps Clinic And Research Foundation Cell surface antigen detection method
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method

Also Published As

Publication number Publication date
FI95082C (fi) 1995-12-11
DK426588A (da) 1988-07-29
JP2803824B2 (ja) 1998-09-24
DE3751331T2 (de) 1996-02-01
DE3751331D1 (de) 1995-07-06
NO172910B (no) 1993-06-14
DK173838B1 (da) 2001-12-10
US5176998A (en) 1993-01-05
FI95082B (fi) 1995-08-31
EP0290595A1 (en) 1988-11-17
AU594554B2 (en) 1990-03-08
ATE123341T1 (de) 1995-06-15
FI883585A (fi) 1988-07-29
US5336597A (en) 1994-08-09
FI883585A0 (fi) 1988-07-29
DK426588D0 (da) 1988-07-29
AU1087688A (en) 1988-06-30
EP0290595B1 (en) 1995-05-31
NO883367D0 (no) 1988-07-29
EP0290595A4 (en) 1990-12-19
NO172910C (no) 1993-09-22
JPH01501571A (ja) 1989-06-01

Similar Documents

Publication Publication Date Title
AU559966B2 (en) Assaying antibody-antigen reactions
NO883367L (no) Celleoverflate-antigen-paavisningsmetode.
IE862504L (en) Monoclonal antibody to leukocytes
NO331074B1 (no) Analysemetode for bestemmelse av holo-Transcobalamin II i en cellefri prove i et kroppsfluid.
DE3270252D1 (en) Radioimmunoassay for fibrinopeptide a
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
DE3674933D1 (de) Spezifisch hemmender speichel-alpha-amylase monoklonaler antikoerper und dessen verwendung zur bestimmung von pankreas-alpha-amylase.
ES8401260A1 (es) "metodo de preparacion de reactivos en particulas, sensibilizados para reacciones inmunologicas".
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
NO881998L (no) Fremgangsmaate til kvantitativ bestemmelse av serumproteiner i kroppsvaesker og middel til gjennomfoering av fremgangsmaaten.
DE3863270D1 (de) Immuntest.
IT9006603A1 (it) Test immunoenzimatico classe specifico per la ricerca e determinazione degli anticorpi anti-cardiolipina nel siero.
DK305084A (da) Partikel samt fremgangsmaade til paavisning af antigener og/eller antistoffer under anvendelse af partiklen

Legal Events

Date Code Title Description
MK1K Patent expired